Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,020 | -2,118 | -3,104 | -2,672 | -1,949 |
| Depreciation Amortization | N/A | 160 | 193 | N/A | 308 |
| Other Working Capital | N/A | 325 | -452 | N/A | N/A |
| Other Operating Activity | 360 | 113 | 79 | 279 | 0 |
| Operating Cash Flow | $-660 | $-1,520 | $-3,284 | $-2,393 | $-1,641 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -7 | -47 | N/A | N/A |
| Other Investing Activity | 0 | -15 | -10 | 152 | 683 |
| Investing Cash Flow | $N/A | $-22 | $-57 | $152 | $683 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | -236 | N/A | 21 |
| Other Financing Activity | 360 | -46 | -185 | 5,801 | 2 |
| Financing Cash Flow | $360 | $-46 | $-421 | $5,801 | $23 |
| Beginning Cash Position | 300 | 1,893 | 5,654 | 1,425 | 1,483 |
| End Cash Position | 10 | 305 | 1,893 | 3,276 | 2,187 |
| Net Cash Flow | $-290 | $-1,588 | $-3,762 | $225 | $1,369 |
| Free Cash Flow | |||||
| Operating Cash Flow | -660 | -1,520 | -3,284 | -2,393 | -1,641 |
| Free Cash Flow | -660 | -1,520 | -3,284 | -2,393 | -1,641 |